Stellettin B (87) appears to act mainly due to the induction of autophagy and apoptosis by interfering with the PI3K/Akt, Stat3, and mTOR signaling pathways in glioblastoma [324,325] and chronic myeloid leukemia cells [319]. Here, STAT3 is linked to glioblastoma.